RESEARCH Open Access Serum

tryptase detected during acute coronary syndrome is significantly related to the development of major adverse cardiovascular 1320 % increase in the odds of developing MACE (p < 0.0001). Pastorello et al. Clinical and Molecular Allergy (2015) 13:14 DOI 10.1186/s12948-015-0013-0Hospital, Milan, Italy Full list of author information is available at the end of the articleConclusion: In ACS patients, serum tryptase measured during index admission is significantly correlated to the development of MACE up to 2 years, demonstrating a possible long-term prognostic role of this biomarker